Intervention of Interest
- semaglutide (Wegovy®) (Novo Nordisk)
For questions please contact [email protected].
View the Key Stakeholder List.
- tirzepatide (Zepbound®) (Eli Lilly and Company)
Assessment Status
Open
Upcoming Milestone
Model Analysis PlanView
Intervention of Interest
For questions please contact [email protected].
View the Key Stakeholder List.
New England CEPAC
The New England CEPAC’s 2025 public meeting on semaglutide and tirzepatide
Public Comments
Closed